The use of serum zinc to prostate-specific antigen ratio as a biomarker in the prediction of prostate biopsy outcomes

dc.contributor.author	Temiz, Mustafa Zafer
dc.contributor.author	Cakir, Omer Onur
dc.contributor.author	Aykan, Serdar
dc.contributor.author	Kucuk, Suat Hayri
dc.contributor.author	Tiryakioglu, Necip Ozan
dc.contributor.author	Bilek, Gunal
dc.contributor.author	Tunali, Nagehan Ersoy
dc.contributor.author	Kandirali, Engin
dc.date.accessioned	16/12/21 12:07
dc.date.available	16/12/21 12:07
dc.date.issued	2019
dc.identifier.issn	1752-0363
dc.identifier.uri	http://dspace.beu.edu.tr:8080/xmlui/handle/20.500.12643/10131
dc.identifier.uri	https://doi.org/10.2217/bmm-2018-0260
dc.description.abstract	Aim: To generate a combination of serum zinc (Zn) and prostate-specific antigen (PSA) in an attempt to provide better prediction of prostate biopsy outcomes with Zn/PSA ratios. Materials & methods: Diagnostic performances of PSA and Zn/PSA were investigat
dc.language.iso	English
dc.publisher	Future Medıcıne Ltd
dc.source	Bıomarkers In Medıcıne
dc.title	The use of serum zinc to prostate-specific antigen ratio as a biomarker in the prediction of prostate biopsy outcomes
dc.type	Article
dc.identifier.issue	2
dc.identifier.startpage	59
dc.identifier.endpage	68
dc.identifier.doi	10.2217/bmm-2018-0260
dc.identifier.wos	WOS:000460728000002
dc.identifier.volume	13

Files in this item

Files	Size	Format	View
There are no files associated with this item.